ARCHIVES

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

ASCO Recommends End of Life Discussions

January 28, 2011

Solomon Garb’s Questions/Answers

December 19, 1980

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

NCI May Give Up Positions From Other Programs To Meet Mandate For CTP Slots

October 19, 1979